| 51 |
16797286 | Conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction. | 2006 Jun |
1 |
| 52 |
16871248 | The place of sirolimus in kidney transplantation: can we reduce calcineurin inhibitor renal toxicity? | 2006 Sep |
1 |
| 53 |
16906035 | Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation. | 2006 Aug 15 |
1 |
| 54 |
16954170 | Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction. | 2006 Nov |
1 |
| 55 |
17048977 | Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients. | 2006 |
2 |
| 56 |
17096757 | Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy. | 2006 Dec |
2 |
| 57 |
17175304 | Calcineurin inhibitor avoidance versus steroid avoidance following kidney transplantation: Postoperative complications. | 2006 Dec |
1 |
| 58 |
15631539 | Management of hyperglycaemia after pancreas transplantation: are new immunosuppressants the answer? | 2005 |
1 |
| 59 |
15760408 | First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation. | 2005 Apr |
1 |
| 60 |
15849545 | The effect of 2-gram versus 1-gram concentration controlled mycophenolate mofetil on renal transplant outcomes using sirolimus-based calcineurin inhibitor drug-free immunosuppression. | 2005 Apr 27 |
1 |
| 61 |
15919502 | Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. | 2005 May |
1 |
| 62 |
15943635 | Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials. | 2005 Jul |
6 |
| 63 |
16162204 | Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation. | 2005 Oct |
1 |
| 64 |
16237714 | Kidney dysfunction in the recipients of liver transplants. | 2005 Nov |
1 |
| 65 |
16303023 | Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials. | 2005 Dec |
1 |
| 66 |
16364861 | Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. | 2005 Dec |
1 |
| 67 |
14762856 | Effect of sirolimus on infection incidence in liver transplant recipients. | 2004 Feb |
1 |
| 68 |
15114090 | Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. | 2004 Apr 27 |
1 |
| 69 |
15256816 | Sirolimus dosage during and after conversion from calcineurin inhibitor therapy to sirolimus in chronic kidney transplant patients. | 2004 |
1 |
| 70 |
15366440 | Sirolimus and mycophenolate mofetil as calcineurin inhibitor-free immunosuppression in a cardiac transplant patient with chronic renal failure. | 2004 Jun |
1 |
| 71 |
15367229 | Effect of sirolimus withdrawal in patients with deteriorating renal function. | 2004 Oct |
1 |
| 72 |
15621119 | Sirolimus addition is beneficial for renal allograft dysfunction due to simultaneous acute rejection episode and calcineurin inhibitor nephrotoxicity. | 2004 Nov |
1 |
| 73 |
12962787 | De novo hemolytic-uremic syndrome/thrombotic microangiopathy in renal transplant patients receiving calcineurin inhibitors: role of sirolimus. | 2003 Aug |
1 |
| 74 |
14612104 | Low-dose sirolimus in combination with mycophenolate in calcineurin inhibitor elimination: the Kuwaiti experience. | 2003 Nov |
1 |
| 75 |
14697970 | Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency. | 2003 Dec |
2 |
| 76 |
12234280 | Fulminant recurrence of atypical hemolytic uremic syndrome during a calcineurin inhibitor-free immunosuppression regimen. | 2002 Aug |
1 |
| 77 |
12372044 | Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent. | 2002 |
5 |
| 78 |
12493414 | Sirolimus rescue treatment in calcineurin-inhibitor nephrotoxicity after kidney transplantation. | 2002 Dec |
1 |
| 79 |
11583938 | Cyclosporine elimination in the presence of TOR inhibitors: effects on renal function, acute rejection, and safety. | 2001 Oct |
1 |
| 80 |
11750386 | Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity. | 2001 Nov-Dec |
1 |
| 81 |
11127307 | A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. | 2000 Dec |
1 |